Purchase Order 223044423
Award Date 4/28/04
Potential Completion Date 6/27/05
Potential Value $26K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jackson, MS 39216, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,248,717.86 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Mississippi State Department of Health (MSDH) Finance & Accounts Division. The contract, which has no set-aside designation, is for the "MISSISSIPPI MQSA NEW CONTRACT" and "MISSISSIPPI MQSA CONTRACT", with a period of performance through January 28, 2028. MSDH, a U.S. state government agency, will provide vital statistics data collection, healthcare...
- This is a $1,558,251.00 Firm Fixed Price federal contract awarded by the Food and Drug Administration (FDA) to the Missouri Department of Health & Senior Services (MDHSS). The contract is for the MISSOURI MQSA INSPECTION CONTRACT, which involves MDHSS conducting inspections of certified non-federal mammography facilities in Missouri to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract was awarded on a sole source basis, as state...
- The U.S. Food and Drug Administration (FDA) awarded a $262,548.81 firm fixed-price contract to the South Dakota Department of Health (SD DOH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, awarded on June 30, 2022, has an ultimate completion date of January 1, 2028. The contract was issued as a sole-source award, as the state government organization is the...
- The Food and Drug Administration (FDA) awarded a $485,906.49 firm fixed-price contract to the Arkansas Department of Health (ADH) to conduct inspections of certified non-federal mammography facilities in Arkansas. This contract, awarded on August 8, 2022, is part of the Mammography Quality Standards Act (MQSA) and runs through August 1, 2027. The contract was awarded as a sole source award, as ADH is the only organization in Arkansas with the legal authority and experience required to perform...
- The U.S. Food and Drug Administration awarded a firm fixed-price purchase order valued at $30,321.90 to the Washington State Department of Health for Mammography Quality Standards Act (MQSA) inspections. The contract was awarded on March 29, 2004, with an ultimate completion date of April 1, 2005, and performed in Tumwater, Washington. No set-aside designation was used for this procurement. The Washington State Department of Health, a state government agency specializing in public health...
- The Food and Drug Administration (FDA) awarded a $236,714.59, firm fixed price definitive contract to the New Hampshire Department of Health and Human Services (NH DHHS) to perform inspections of certified non-federal mammography facilities in New Hampshire. This contract, which runs through March 31, 2028, is to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract was not set aside and was competitively awarded to the state agency, which...
- The Food and Drug Administration (FDA) awarded a definitive firm fixed-price contract valued at $1.59M to the Alabama Department of Public Health (ADPH) on September 15, 2022, for mammography quality standards inspections. The contract, which extends through March 31, 2028, requires ADPH to conduct inspections of certified non-federal mammography facilities throughout Alabama to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). As a state health...
- The Food and Drug Administration awarded a firm fixed price definitive contract valued at one million one hundred thirty thousand fifteen dollars and eighty-one cents ($1,130,015.81) to the Florida Department of Health for MQSA inspections. The place of performance is Tallahassee, Florida. No set-aside designation was used for this contract. As the designated state health agency for Florida, the Department of Health will utilize its resources across the state to conduct Mammography Quality...
- This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
- This federal contract award, valued at $490,298.00, was issued by the Food and Drug Administration (FDA) to the State of Montana Department of Health and Human Services (DPHHS) for MQSA inspections within the state of Montana. The contract is a definitive, firm fixed-price contract with an ultimate completion date of April 23, 2028. The award does not have a set-aside designation. DPHHS, a comprehensive state government agency, will provide specialized regulatory inspection services to the FDA...